- Custom synthesis of 14C labelled compounds to support pre-clinical ADME studies
- GMP synthesis of 14C labelled compounds for human AME studies
- Expertise and facilities for handling labelled gases and volatiles including Carbon Dioxide, Carbon Monoxide and Methyl Iodide.
Projects can be supported either by separate complete syntheses of non-clinical and clinical batches, or by synthesis of a pre-clinical intermediate, which can be used to prepare non-clinical and clinical batches. This second approach can avoid the need for a re-synthesis, saving both time and cost when providing labelled material for the hAME study.
MHRA SymposiumThe 2018 MHRA Symposium will be attended by John McRoberts, Head of QA.
MHRA SymposiumDates: 20th NovemberLocation: London, UK
AAPS: PharmSci360This years' PharmSci360 conference will be attended by Masha Kononov, Senior Director Emerging Biotech US.
AAPS: PharmSci360Dates: 4th - 7th NovemberLocation: Washington DC, US
Bio-Europe 2018Bio-Europe autumn conference will be attended by Nathalie Huther, Business Development Manager Europe.
Bio-Europe 2018Dates: 5th - 7th NovemberLocation: Copenhagen, Denmark